Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PDLI | AZN | AMGN | GILD | VRTX |
| Company | Pdl Biopharma Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.73 | 90.37 | 329.09 | 120.98 | 455.65 |
| High | 2.78 | 90.48 | 329.67 | 122.37 | 457.17 |
| Low | 2.39 | 89.67 | 322.02 | 120.59 | 441.32 |
| Latest | 2.47 | 90.21 | 322.98 | 120.93 | 440.82 |
| Change | -0.23 | +0.03 | -6.91 | -0.29 | -14.66 |
| % Change | -8.52% | +0.03% | -2.09% | -0.24% | -3.22% |
| Volume | 30,270,700 | 4,144,584 | 1,287,534 | 1,976,608 | 671,821 |
| 20-Day Average Volume | 4,709,610 | 5,392,041 | 2,812,466 | 6,789,634 | 1,376,530 |
| Previous Close | 2.70 | 90.18 | 329.89 | 121.22 | 455.48 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.58 | 90.11 | 337.72 | 124.48 | 434.81 |
| 20-Day Raw Stochastic | 17.78% | 52.33% | 19.56% | 38.29% | 66.58% |
| 20-Day Relative Strength | 46.04 | 59.00 | 51.30 | 48.76 | 57.95 |
| Weighted Alpha | -24.80 | +38.44 | +21.21 | +29.46 | -0.23 |
| Today's Opinion | 64% Sell | 100% Buy | 80% Buy | 80% Buy | 40% Buy |
| Previous Opinion | 40% Sell | 100% Buy | 80% Buy | 80% Buy | 40% Buy |
| Last Month's Opinion | 56% Sell | 100% Buy | 56% Buy | 100% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.26% since 12/22/20 | -0.44% since 12/01/25 | -3.76% since 12/01/25 | -2.23% since 12/01/25 | +4.80% since 12/01/25 |
| Low | 2.39 on 12/30/20 | 89.68 on 12/08/25 | 322.02 on 12/08/25 | 120.38 on 12/05/25 | 424.06 on 12/02/25 |
| High | 2.84 on 12/29/20 | 91.28 on 12/03/25 | 346.38 on 12/03/25 | 125.60 on 12/03/25 | 463.85 on 12/03/25 |
| 1-Month | |||||
| %Chg | -2.37% since 11/30/20 | +6.55% since 11/07/25 | +1.43% since 11/07/25 | +2.29% since 11/07/25 | +8.93% since 11/07/25 |
| Low | 2.39 on 12/30/20 | 85.85 on 11/10/25 | 319.54 on 11/10/25 | 117.13 on 11/10/25 | 410.50 on 11/10/25 |
| High | 2.84 on 12/29/20 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | -21.59% since 09/30/20 | +10.50% since 09/08/25 | +15.92% since 09/08/25 | +4.90% since 09/08/25 | +12.85% since 09/08/25 |
| Low | 2.09 on 11/02/20 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 3.24 on 10/01/20 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | -15.12% since 06/30/20 | +23.66% since 06/06/25 | +11.87% since 06/06/25 | +8.09% since 06/06/25 | -0.99% since 06/06/25 |
| Low | 2.09 on 11/02/20 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 3.78 on 08/19/20 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 282,141 | 279,686,592 | 177,639,520 | 150,395,232 | 115,563,928 |
| Shares Outstanding, K | 114,227 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 54,760,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -70,410,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 4,120,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | 4,400,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.11 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 12/31/21 | 11/06/25 | 11/04/25 | 10/30/25 | 11/03/25 |
| Most Recent Dividend | 0.050 on 06/02/16 | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | 09/21/20 | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.70 | 15.55 | 14.97 | 29.87 |